Obesity Correlates with Chronic Inflammation of the Innate Immune System in Preeclampsia and HELLP Syndrome during Pregnancy.

HDP HELLP NETosis PMNs ROS neutrophils obesity preeclampsia pregnancy

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
20 Oct 2023
Historique:
received: 13 09 2023
revised: 14 10 2023
accepted: 19 10 2023
medline: 28 10 2023
pubmed: 28 10 2023
entrez: 28 10 2023
Statut: epublish

Résumé

HELLP syndrome is characterized by hemolysis, elevated liver enzymes, and a low platelet count and poses an increased risk to the pregnant woman and the unborn child. Individual risk factors such as obesity may alter immunocompetence and influence the course of preeclampsia (PE) or HELLP syndrome. Blood samples were collected from 21 pregnant women (7 healthy, 6 with PE, and 8 with HELLP syndrome) and polymorphonuclear neutrophils (PMNs) were subsequently isolated. Production of radical oxygen species (ROS), cell movement, and NETosis were assessed by live-cell imaging. Surface protein expression and oxidative burst were analyzed by flow cytometry. PE and HELLP patients had significantly higher BMI compared to the healthy control group. Depending on the expression of CD11b, CD62L, and CD66b on PMNs, a surface protein activation sum scale (SPASS) was calculated. PMNs from patients with high SPASS values showed prolonged and more targeted migration with delayed ROS production and NETosis. Obesity is associated with a chronic inflammatory state, which in combination with immunological triggers during pregnancy could modulate PMN functions. Pregnant women with higher BMI tend to have higher SPASS values, indicating activation of the innate immune system that could co-trigger PE or HELLP syndrome.

Identifiants

pubmed: 37893224
pii: biomedicines11102851
doi: 10.3390/biomedicines11102851
pmc: PMC10604126
pii:
doi:

Types de publication

Journal Article

Langues

eng

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

Front Immunol. 2021 Jun 24;12:674079
pubmed: 34248955
Immun Inflamm Dis. 2021 Dec;9(4):1186-1196
pubmed: 34472718
Am J Obstet Gynecol. 1998 Jul;179(1):80-6
pubmed: 9704769
J Obstet Gynaecol. 2013 May;33(4):331-7
pubmed: 23654309
J Immunol Res. 2020 Aug 17;2020:1415947
pubmed: 32879894
Immun Inflamm Dis. 2021 Dec;9(4):1237-1251
pubmed: 34115923
J Infect Dis. 2021 Aug 16;224(4):575-585
pubmed: 34398243
J Soc Gynecol Investig. 1999 May-Jun;6(3):136-41
pubmed: 10376269
N Engl J Med. 2016 Jan 7;374(1):13-22
pubmed: 26735990
BJOG. 2021 Jul;128(8):1282-1291
pubmed: 33539617
Placenta. 2011 Feb;32 Suppl:S21-9
pubmed: 20541258
J Obstet Gynaecol Res. 2021 Jul;47(7):2318-2323
pubmed: 33973302
Thromb Haemost. 2018 Dec;118(12):2064-2073
pubmed: 30453347
Z Geburtshilfe Neonatol. 2014 Feb;218(1):34-41
pubmed: 24595913
Br J Haematol. 1995 Sep;91(1):46-54
pubmed: 7577651
Am J Obstet Gynecol. 2007 Jan;196(1):48.e1-8
pubmed: 17240230
Pregnancy Hypertens. 2022 Mar;27:42-50
pubmed: 34915395
Hypertens Pregnancy. 2008;27(4):396-405
pubmed: 19003640
Innate Immun. 2018 May;24(4):203-209
pubmed: 29635958
J Thromb Haemost. 2005 Nov;3(11):2563-70
pubmed: 16241954
Hum Reprod Update. 2012 Jul;18(4):436-57
pubmed: 22495259
Am J Obstet Gynecol. 1999 Aug;181(2):408-14
pubmed: 10454692
Am J Reprod Immunol. 2014 Apr;71(4):379-86
pubmed: 24612145
Haemostasis. 1999 Sep;29(1):41-9
pubmed: 10494033
Am J Reprod Immunol. 2006 Aug;56(2):135-44
pubmed: 16836616
Reprod Sci. 2020 Nov;27(11):2115-2127
pubmed: 32542542
Am J Obstet Gynecol. 2004 Jan;190(1):252-8
pubmed: 14749668
J Anat. 2009 Jul;215(1):21-6
pubmed: 19215319
Immunology. 2021 Dec;164(4):701-721
pubmed: 34547115
J Leukoc Biol. 2022 Jan;111(1):237-260
pubmed: 33847419
Cardiovasc Ther. 2020 Apr 25;2020:9783630
pubmed: 32405324
Am J Obstet Gynecol. 2001 Oct;185(4):792-7
pubmed: 11641653
Br J Haematol. 1995 Dec;91(4):846-53
pubmed: 8547128
Medicina (Kaunas). 2022 Feb 21;58(2):
pubmed: 35208649
Eur J Obstet Gynecol Reprod Biol. 2013 Feb;166(2):117-23
pubmed: 23107053
Cell Mol Immunol. 2021 Apr;18(4):979-991
pubmed: 33707686
Immunol Rev. 2016 Sep;273(1):180-93
pubmed: 27558335
Am J Obstet Gynecol. 2000 Dec;183(6):1558-63
pubmed: 11120528
Front Immunol. 2021 Dec 23;12:767175
pubmed: 35003081
Transfusion. 2019 Jun;59(6):2121-2130
pubmed: 30934131

Auteurs

Julia Rimboeck (J)

Department of Anesthesiology, University Hospital of Regensburg, 93042 Regensburg, Germany.

Michael Gruber (M)

Department of Anesthesiology, University Hospital of Regensburg, 93042 Regensburg, Germany.

Marco Weigl (M)

University Department of Obstetrics and Gynecology at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, 93049 Regensburg, Germany.

Pia Huber (P)

Department of Anesthesiology, University Hospital of Regensburg, 93042 Regensburg, Germany.

Dirk Lunz (D)

Department of Anesthesiology, University Hospital of Regensburg, 93042 Regensburg, Germany.

Walter Petermichl (W)

Department of Anesthesiology, University Hospital of Regensburg, 93042 Regensburg, Germany.

Classifications MeSH